Imcivree Setmelanotide Acetate — Blue Cross Blue Shield Of Oklahoma
7 indications indexed for this drug.
- Any Other Fda Labeled IndicationView coverage criteria
- Compendia Supported IndicationView coverage criteria
- Monogenic Obesity Due To Leptin Receptor Lepr DeficiencyView coverage criteria
- Monogenic Obesity Due To Proopiomelanocortin Pomc DeficiencyView coverage criteria
- Monogenic Obesity Due To Proprotein Convertase Subtilisin KeView coverage criteria
- Other Indication Supported By Peer Reviewed Clinical LiteratView coverage criteria
- Syndromic Obesity Due To Bardet Biedl Syndrome BbsView coverage criteria